/>

Vaccination for 12-14 age group likely from March: NTAGI chief

Coverage of the 15-17 population making good progress, says N.K. Arora

Updated - January 18, 2022 08:31 am IST - New Delhi

Wider reach:  A 16-year-old student gets her first dose of vaccination in Delhi on Saturday.

Wider reach: A 16-year-old student gets her first dose of vaccination in Delhi on Saturday.

India may begin inoculating children in the 12-14 age group against COVID-19 in March as the 15-17 population is likely to get fully vaccinated by then, N.K. Arora, Chairman of the COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI), said on Monday.

Of the estimated 7.4 crore population in the 15-17 age bracket, over 3.45 crore have received the first dose of Covaxin so far and their second dose is due in 28 days, he said.

Active participants

“Adolescents in this age group have been actively participating in the inoculation process, and going by this pace of vaccination, the rest of the beneficiaries in the 15-17 age group are likely to be covered with the first dose by January-end and subsequently their second dose is expected to be done by February-end,” he said.

Once the 15-17 age group is covered, he said, the government is likely to take a policy decision for initiating the vaccination drive for the 12-14 age group in March. According to him, there is an estimated 7.5 crore population in the 12-14 age group.

Provisional vaccination reports till 7 a.m. on Monday showed that with more than 39 lakh doses being administered in a span of 24 hours, the cumulative number has exceeded 157.2 crore doses. According to government data, over 3.45 crore first doses have been given to children in the 15-17 years age group so far.

India began administering the “precaution dose”, a third jab of COVID-19 vaccine, to healthcare and frontline workers, including personnel deployed for election duty and those aged 60 and above with co-morbidities, from January 10 amid the country witnessing a spike in coronavirus infections, driven mainly by the Omicron variant of the virus.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.